SAN CARLOS, Calif.--(BUSINESS WIRE)--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced today positive top-line ...
Analysis results highlight the efficacy of cough suppression therapy (CST) for those with chronic refractory cough and voice disorders. Results of a retrospective analysis show cough suppression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback